Dermatol. praxi. 2017;11(1):22-26 | DOI: 10.36290/der.2017.005

News in the treatment with peroral isotretinoin

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna, Dermatovenerologické oddělení, Nemocnice Jihlava

Acne is a polymorphic inflammatory disease of a pilosebaceous unit. Peroral isotretinoin belongs to the first non-aromatic generation

of retinoids and is the most effective medicine in acne treatment. It is indicated first of all for a therapy of severe and resistent

forms of acne. The therapy should by directed only by a dermatologist who is experienced in the treatment with this medicine.

In the article the latest recommentations for isotretinoin therapy including special arrangement for women are described.

Keywords: acne, treatment, isotretinoin, treatment recommendations

Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. News in the treatment with peroral isotretinoin. Dermatol. praxi. 2017;11(1):22-26. doi: 10.36290/der.2017.005.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Layton AM. The use of isotretinoin in acne. Dermatoendocrinol, 2009; 1(3): 162-169. Go to original source... Go to PubMed...
    2. Rawlings AV. The molecular biology of retinoids and their receptors. In Webster, G. et al. Acne and its therapy. New York: Informa Healthcare 2007: 45-53. Go to original source...
    3. Nelson AM, Gilliland KL, Cong Z. 13-Cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 2006; 126(10): 2178-2189. Go to original source... Go to PubMed...
    4. Karlsson T, Vahlquist A, Kedishvili N, et al. 13-Cis retinoic acid competitevely inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenace RoDH-4: a mechanism for its anti-androgenetic effects in sebaceous glands? Biochem Biophys Res Commun 2003; 303(1): 273-278. Go to original source... Go to PubMed...
    5. Lumsden KR, Thiboutot DM, et al. Isotretinoin Increases Skin Surface Levels of Neutrophil Gelatinase-Associated Lipocalin in Patients Treated for severe acne. Br J Dermatol 2011: 1365-1375. Go to original source... Go to PubMed...
    6. Landthales M, Kummermehr J, Wagner A, et al. Inhibitory effects of 13-cis-retinoid acid on human sebaceous glands. Arch Dermatol Res 1980; 269: 297-309. Go to original source... Go to PubMed...
    7. Leyden JJ, Mc Ginley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986; 86(4): 390-393. Go to original source... Go to PubMed...
    8. Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemic Isotretinoin Normalizes Exaggerated TLR-2-Mediated Innate Immune Respones in Acne Patients. J Invest Dermatol, advance online publication 19 April 2012, doi: 10.1038/jid.2012.111. Go to original source... Go to PubMed...
    9. Goldman R. Effect of retinoic acid on the proliferation and phagocytic capability of murine macrophage-like cell lines. J Cell Physiol 1984; 120: 91-102. Go to original source... Go to PubMed...
    10. Orfanos CE, Bauer R. Evidence for anti-inflammatory activities of oral syntetic retinoids: experimental findings and clinical experience. Br J Dermatol 1983; 109: 55-60.
    11. Holland DB, Jeremy AH, Roberts SG, et al. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 2004; 150: 72-81. Go to original source... Go to PubMed...
    12. Zoubolis CC. Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy. J Eur Acad Dermatol Venereol 2001; 15: 63-67. Go to original source... Go to PubMed...
    13. Boman HG. Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scand J Immunol 1998; 48: 15-25. Go to original source... Go to PubMed...
    14. Rulcová J, Vaněčková J. Léčba acne vulgaris. Maxdorf-Jessenius 2001, ISBN 80-85912-56-2: 20-28.
    15. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol, 1986; 25: 660-663. Go to original source... Go to PubMed...
    16. Nast A, Dréno B, Bettoli V, et al. European Evidence-based (S3) Guidelines for the Treatment of Acne. J Eur Acad Dermatol Venereol, 2012; 26(Suppl. 1): 1-29. Go to original source... Go to PubMed...
    17. Gollnick HPM, et al. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol,2016 epub. DOI: 10.1111/jdv.13675. Go to original source... Go to PubMed...
    18. Nevoralová Z. Udržovací léčba akné. Dermatol praxi 2016; 10(1): 10-15. Go to original source...
    19. Nevoralová Z. Izotretinoin v praxi. Mladá fronta 2012, ISBN 978-80-204-2695-6.
    20. Aravilskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Am Acad Dermatol 2016; 30: 926-935. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.